Not Just Another Hospital,
But Another Path to Treatment.
For cancer patients worldwide, we connect precision diagnosis and multidisciplinary evaluation with 20+ oncology treatment technologies to explore more possibilities for complex, recurrent and metastatic disease.
Why Are More International Patients
Coming to Guangzhou for Their Next Treatment Option?
It is not simply about seeking treatment in another country. It is about reassessing the possibilities — with access to more technologies, more treatment options, stronger multidisciplinary collaboration and a more coordinated care pathway.
to “Which options can we still consider?” Advanced oncology care · Multidisciplinary treatment · International patient support
Precision radiotherapy, interventional therapy, ablation, robotic surgery, targeted therapy and immunotherapy can be evaluated together as part of one coordinated treatment strategy.
Complex cases are reviewed by specialists from different disciplines to determine treatment priorities and reduce the limitations of a single-specialty perspective.
PET/MR, medical imaging, pathology and other necessary tests help reassess staging, disease extent and the remaining treatment possibilities.
Diagnostics, hospitalization, specialist consultations and oncology treatment can be coordinated within one integrated hospital system to improve treatment efficiency.
One Cancer Diagnosis
Should Not Have Only One Answer.
True personalized treatment does not place every patient into the same protocol. It means selecting and combining the most appropriate treatment pathways based on tumor location, stage, previous treatments, physical condition and treatment goals.
It Is About Which Combination Best Fits the Patient. Precision Radiotherapy · Surgery · Interventional Oncology · Targeted Therapy · Immunotherapy
More Treatment Options Create More Possibilities for the Right Combination.
For patients with complex, recurrent or metastatic disease, a single treatment is often not enough. A multi-platform approach allows the MDT to balance local treatment, systemic therapy and the patient’s overall tolerance more precisely.
About Us
The Cancer Center at Jinshazhou Hospital of Guangzhou University of Chinese Medicine provides cancer diagnosis, multidisciplinary team (MDT) consultation, precision radiotherapy and comprehensive oncology treatment, together with coordinated medical services for international patients from evaluation and treatment through follow-up care.
The Value of Technology Is Not in Its Specifications, but in the Problems It Helps Solve for Patients.
Intracranial Tumor in a 9-Year-Old Child
High-precision radiotherapy was used to control the lesion while minimizing radiation exposure to surrounding critical brain structures as much as possible.
Precision is not only about targeting the tumor — it is also about protecting a child’s future quality of life as much as possible during treatment.
Stage IIIB Cervical Cancer · Large Tumor Case
External beam radiotherapy was combined with brachytherapy to intensify local treatment through coordinated external and intracavitary radiation.
Definitive Radiotherapy for Nasopharyngeal Cancer
TomoTherapy can provide precise dose coverage for complex head and neck targets while limiting radiation exposure to nearby critical organs as much as possible.
Bladder Cancer · Adaptive Radiotherapy Case
The bladder can change in size and position from day to day. Ethos can use daily imaging to reassess anatomy and support online adaptive planning in suitable cases.
Precision Radiotherapy for Nasopharyngeal Cancer
Image guidance together with IMRT / VMAT can help cover the tumor target while also protecting surrounding normal tissues.
Bladder Cancer · High-Efficiency Precision Radiotherapy
Halcyon emphasizes rapid image guidance and an efficient treatment workflow, helping reduce time on the treatment couch in suitable cases.
Stereotactic Radiotherapy for a Liver Tumor
For liver lesions that move with respiration, CyberKnife can combine tracking technology with high-precision treatment in suitable cases.
Multiple Brain Metastases · Integrated High-Precision Treatment
HyperArc provides an automated non-coplanar stereotactic radiotherapy workflow for multiple intracranial targets, enabling high-precision planning and treatment of multiple brain metastases in suitable patients.
Proton Therapy · Further Normal-Tissue Protection for Selected Patients
By using the physical properties of the Bragg Peak, proton therapy can reduce unnecessary dose to some normal tissues and may be particularly valuable for children and tumors located near critical organs.
High Case Volume,
Building High-Density Clinical Experience.
Cancer treatment depends not only on equipment and technology, but also on the clinical judgment developed through long-term experience with a high volume of complex and diverse cases. In a high-volume oncology environment, doctors more frequently face difficult decisions involving different stages, recurrence, metastases and disease progression after previous treatments.
Experience Is Not Just About “Doing More” —
It Is About Seeing More Complex Situations.
Hospital data indicate approximately 600 radiotherapy sessions per day and more than 60,000 cancer patients treated annually. This continuous, high-density clinical exposure provides an important experience base for radiotherapy planning, complication management, complex metastatic disease and multidisciplinary decision-making.
Beyond Precision Treatment,
We Also Focus on the Patient as a Whole.
Alongside standard oncology treatment, an integrated Chinese and Western medicine care approach may also focus on treatment tolerance, symptom control, nutrition, recovery status and long-term management.
The Biggest Risk in Cancer Treatment Is Not “Having No Options” — It Is When Each Specialty Sees the Problem Only from Its Own Perspective.
Complex cancers often involve surgical resectability, radiotherapy dose, systemic treatment response, organ function and future quality of life at the same time. The purpose of MDT is to bring the perspectives of different specialties together before treatment begins.
“Operate First and Decide Later” May Reveal Unexpected Complexity Only After Surgery Has Begun.
In some complex tumors, if the extent of invasion, vascular involvement or distant metastases are not fully assessed before surgery, the team may only discover during the operation that complete and safe resection is not possible — and the procedure may even need to be stopped.
“Try Intensive Chemotherapy First” Is Not Necessarily Right for Every Patient.
If molecular subtype, tumor burden, local symptoms and other treatment opportunities are not considered together, using chemotherapy simply as a “first try” may expose the patient to significant side effects and may also delay a more suitable local or combined treatment opportunity.
Radiotherapy Is Not About “More Dose Is Better” — It Requires Full Consideration of the Target and Normal Tissues.
Whether using photon therapy, particle therapy or other precision radiotherapy techniques, the goal is not simply to increase dose. The target area, organ tolerance, previous radiation history and overall systemic treatment strategy must be considered together to control the tumor while avoiding unnecessary damage to normal tissues.
Then Choose the Technology.
Surgery, radiation oncology, medical oncology, interventional oncology, imaging and pathology work together, allowing possible pathways, risks and alternatives to be discussed before treatment begins.
From Your First Consultation,
to Arriving in Guangzhou for Treatment.
For international patients, the biggest concern is often not the treatment itself, but knowing what to do first, what to prepare and who will assist after arriving in Guangzhou. That is why the entire journey should be as simple, clear and efficient as possible.
We Can Start Coordinating the Next Step.
After receiving your medical reports, the team can first organize and conduct a preliminary review, then coordinate an online consultation, treatment timing and travel arrangements to Guangzhou, helping reduce uncertainty from long waiting times and repeated registration processes.
Once the Treatment Plan Is Confirmed,
You Can Begin Preparing for the Journey.
Treatment May End,
but Medical Continuity Should Not.
After returning home, international patients may still need follow-up examinations, medication, imaging assessment or adjustments to the next stage of treatment. That is why care in Guangzhou and continued medical follow-up at home are considered as part of one connected pathway.
but About Maintaining Continuity of Care.
Before discharge, treatment records and follow-up plans are organized. After returning home, local examinations, medication and online reassessment can be coordinated as needed, allowing the China-based treatment team to remain informed of subsequent changes.
Guangzhou connects with
your continuing care at home.
HOSPITAL
GUANGZHOU
Real Treatment Experiences,
Helping You Make More Informed Medical Decisions.
From complex cancer treatment to the experiences of elderly patients, we share real patient journeys together with hospital technologies, the treatment environment and practical information for international patients — helping you gain a clearer and more complete understanding before making a decision.
Not Sure What the Next Treatment Step Should Be?
Start with a Medical Review.
If you are considering further evaluation or treatment in Guangzhou, you can begin by submitting your existing medical reports, imaging and treatment records. The medical team will review the available information to better understand your condition and discuss whether further assessment or treatment options may be appropriate.